US2016031798A1PendingUtilityA1

2-amino-3-methyl-hex-5-enoic acid and its use in the prodction of peptides such as bacitracins

37
Assignee: XELLIA PHARMACEUTICALS APSPriority: Oct 28, 2009Filed: Sep 9, 2015Published: Feb 4, 2016
Est. expiryOct 28, 2029(~3.3 yrs left)· nominal 20-yr term from priority
Inventors:Martin ManssonChristine SenstadJon EfskindVidar Bjornstad
C07K 7/58C07C 229/30C07D 307/54C07B 2200/07C07C 229/34C07C 227/16C07C 229/08
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention concerns 2-amino-3-mmethyl-hex-5-enoic acid, its use for the production of peptides such as bacitracins and a method for producing it.

Claims

exact text as granted — not AI-modified
1 . A peptide comprising a 2-amino-3-methyl-hex-5-enoic acid residue having the following side chain 
       
         
           
           
               
               
           
         
         wherein the peptide is not a bacitracin. 
       
     
     
         2 . A composition comprising 2-amino-3-methyl-hex-5-enoic acid. 
     
     
         3 . The composition of  claim 2 , wherein the 2-amino-3-methyl-hex-5-enoic acid is in the (2S,3S) configuration. 
     
     
         4 . The composition of  claim 2 , wherein the 2-amino-3-methyl-hex-5-enoic acid is in the (2R,3S) configuration. 
     
     
         5 . The composition of  claim 2 , wherein the 2-amino-3-methyl-hex-5-enoic acid is in the (2S,3R) configuration. 
     
     
         6 . The composition of  claim 2 , wherein the 2-amino-3-methyl-hex-5-enoic acid is in the (2R,3R) configuration 
     
     
         7 . The composition of  claim 2 , in the form of a pharmaceutical composition comprising a pharmaceutically acceptable excipient.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.